Results 141 to 150 of about 1,829,207 (256)

Proof-of-concept trial of PP-01 for mitigating cannabis withdrawal syndrome in participants with cannabis use disorder. [PDF]

Am J Addict
Slagle AF, Constantine J, Kushner H, Graham S, Constantine G.   +4 more
europepmc   +1 more source

Status epilepticus: Updates on mechanisms and treatments

Epilepsia Open, EarlyView.
Abstract Status epilepticus (SE) consists of prolonged, self‐sustaining seizures and is a common neurological emergency that causes respiratory compromise and neuronal injury. Without prompt treatment, the seizures can become resistant to benzodiazepines, leading to the progressive evolution of established, refractory, and super‐refractory SE.
Suchitra Joshi, Jaideep Kapur
wiley   +1 more source

Responding to medetomidine in Philadelphia: narrative summary of the public health response to a new psychoactive substance. [PDF]

Addict Sci Clin Pract
Warrick-Stone T, Simpson SE, Durney P, Goodstein D, Abrams C, Bobb R, London K, Teixeira da Silva D.   +7 more
europepmc   +1 more source

Functional/dissociative seizures as a manifestation of forced normalization in eyelid myoclonia with absence epilepsy

Epileptic Disorders, EarlyView.
Fernando Vasquez‐Lopez, Jimena Gonzalez‐Salido, Salvador Martínez‐Medina, Irving Fuentes‐Calvo, Diego A. Barrios‐González, Betsy C. Vázquez‐Cruz, Juan Carlos Vera‐López, Jimena Colado‐Martinez, Orelli Ruiz‐Rodríguez, Pilar Robles‐Lomelin, Maximiliano Salgado Deza, Diego A. Hernandez, Álvaro José Moreno Avellán, Mario A. Sebastián Díaz, Daniel Crail‐Meléndez, Ángel Ruiz‐Chow, Iris E. Martínez‐Juárez   +16 more
wiley   +1 more source

Long‐term developmental outcome in infantile epileptic spasms syndrome after high‐dose prednisolone and vigabatrin treatment

Epilepsia Open, EarlyView.
Abstract Objective To evaluate long‐term developmental outcomes and identify independent predictors of favorable developmental outcomes at 3 years of age in children with infantile epileptic spasms syndrome (IESS) treated with a standardized stepwise vigabatrin and high‐dose prednisolone protocol.
Soyoung Jang, Hui Jin Shin, Se Hee Kim, Joon Soo Lee, Ara Ko, Hoon‐Chul Kang   +5 more
wiley   +1 more source

Effects of simulated and real opioid withdrawal on delay discounting for opioids and money in people who use fentanyl daily. [PDF]

Exp Clin Psychopharmacol
Shellenberg TP, Baidwan T, Johansen AN, Strickland JC, Martinez S, Regnier SD, Wesley MJ, Babalonis SL, Stoops WW, Lile JA.   +9 more
europepmc   +1 more source

Effectiveness and safety of cannabidiol in adult patients with epilepsy: A multicenter, retrospective study

Epilepsia Open, EarlyView.
Abstract Objective Cannabidiol (CBD) has demonstrated promising effectiveness and tolerability as adjunctive treatment in patients with severe childhood epilepsies. This study investigated the effectiveness and tolerability of CBD in adults with a history of Dravet syndrome (DS), Lennox–Gastaut syndrome (LGS), or tuberous sclerosis complex (TSC ...
Sara Sánchez‐Gamino, María Isabel Chamorro Muñoz, Pedro J. Serrano‐Castro, Pablo Hernández‐Vitorique, Lucía Rodríguez Jiménez, Yolanda López Moreno, Pablo Cabezudo‐García, Guillermina García Martín   +7 more
wiley   +1 more source

Barriers to Maternal Presence at the Bedside of Infants With Neonatal Opioid Withdrawal Syndrome. [PDF]

Cureus
Guth A, Gangemi-Hanninen A, Divatia H.
europepmc   +1 more source

Stability of the Epileptogenic Index across seizures and the effects of sleep and withdrawal of anti‐seizure medications

Epilepsia Open, EarlyView.
Abstract Objective Epileptogenic Index (EI) is a promising index to evaluate the epileptogenicity of the brain tissue and is useful in planning epilepsy surgery. We aimed to evaluate whether EI maps are consistent across seizures within patients and whether EI‐derived measures are affected by the vigilance state and anti‐seizure medication (ASM) dose ...
May Bar‐On, Noam Ben‐Eliezer, Noam Fallik, Lilac Goldstein, Guy Gurevitch, Ido Strauss, Inbal Maidan, Firas Fahoum   +7 more
wiley   +1 more source

Transcutaneous auricular vagus nerve stimulation in drug‐resistant epilepsy: A randomized, sham‐controlled crossover trial with exploratory EEG and MRI response phenotyping

Epilepsia Open, EarlyView.
Abstract Objective Transcutaneous auricular vagus nerve stimulation (taVNS) is a noninvasive neuromodulation strategy for drug‐resistant epilepsy, but clinical response is heterogeneous. We examined whether electroencephalographic (EEG) and structural magnetic resonance imaging (MRI) phenotypes were associated with active‐specific clinical benefit from
Sung Jun Hong, Seok‐Yeol Yang, Eun Kyung Bok, Jung Chul Lee, Yeonggin Kim, Kyousik Min, Young‐Min Shon   +6 more
wiley   +1 more source